8.460USD+1.01%Mkt Cap: 662.29M USDP/E: 3.89Last update: 2026-06-01
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an an…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap662.29M USD
Enterprise Value631.46M USD
Revenue (TTM)400.05M USD
Gross Profit275.75M USD
Net Income (TTM)163.06M USD
Revenue/Share5.292 USD
Last Price8.460 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees191
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS21900C3088
Valuation
P/E (Trailing)3.89
P/E (Forward)24.11
PEG—
EV/EBITDA2.76
EV/Revenue1.58
P/S1.66
P/B1.51
EPS (TTM)2.17
EPS (Forward)0.35
52W Range
6.13021% of range17.43
52W High17.43 USD
52W Low6.130 USD
Profitability
Gross Margin88.46%
Oper. Margin49.96%
EBITDA Margin57.19%
Profit Margin52.31%
ROE40.23%
ROA19.74%
Growth
Revenue Growth226.10%
Earnings Growth42.80%
Cash Flow & Leverage
Operating CF175.05M USD
CapEx (TTM)2.26M USD
FCF Margin29.96%
FCF Yield18.09%
Net Debt-30.67M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.37
Current Ratio2.98
Quick Ratio2.58
Book Value/Sh5.575 USD
Cash/Share2.270 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 26, 2019
Splits
Last Split1:5
Split DateMar 26, 2019
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)15.33 USD
Target Range13.00 USD – 19.00 USD
# Analysts6
Ownership
Shares Out.78.45M
Float66.55M
Insiders7.51%
Institutions54.91%
Short Interest
Short Ratio12.7d
Short % Float20.07%
Short % Out.19.81%
Shares Short15.54M
Short (prev mo.)15.72M
Technical
SMA 507.393 (+14.4%)
SMA 2009.531 (-11.2%)
Beta1.46
S&P 52W Chg27.94%
Avg Vol (30d)1.20M
Avg Vol (10d)1.82M
Technical Indicators
RSI (14)62.2
MACD0.2443
MACD Signal0.1960
MACD Hist.+0.0483
BB Upper8.519 USD
BB Middle7.938 USD
BB Lower7.357 USD
BB Width14.64%
ATR (14)0.3419 USD
Vol Ratio (20d)0.47x